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Summary
Chemotaxis, migration towards soluble chemical cues, is critical for processes such as wound 
healing and immune surveillance, and is exhibited by various cell types from rapidly-migrating 
leukocytes to slow-moving mesenchymal cells. To interrogate the mechanisms involved in 
mesenchymal chemotaxis, we observed cell migration in microfluidic chambers that generate 
stable gradients of the chemoattractant PDGF. Surprisingly, we found that pathways implicated in 
amoeboid chemotaxis, such as PI3K and mTOR signaling, are dispensable for chemotaxis to 
PDGF. Instead, we find that local inactivation of Myosin IIA, through a non-canonical Ser1/2 
phosphorylation of the regulatory light chain, is essential. This site is phosphorylated by PKCα, 
which is activated by an intracellular gradient of diacylglycerol generated by PLCγ. Using a 
combination of TIRF imaging and gradients of activators/inhibitors in the microfluidic chambers, 
we demonstrate that this signaling pathway and subsequent inhibition of Myosin II activity at the 
leading edge is required for mesenchymal chemotaxis.
Introduction
Chemotaxis, or directed cell migration towards a soluble cue, is a critical process for many 
physiological events such as wound healing, immune responses and angiogenesis, and has 
been studied for nearly a century (Swaney et al., 2010). This process is not limited to 
metazoans or even eukaryotes, as free-living cells such as amoebae and bacteria must 
chemotax to find nutrients or more favorable environmental conditions (Sourjik and 
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Wingreen, 2012). Despite the long history of chemotaxis studies, many important questions 
about how this process works and the diversity of chemotactic mechanisms remain 
unresolved.
Chemotactic ligands can stimulate a variety of signaling pathways involving G-protein 
coupled receptors (GPCRs), receptor tyrosine kinases (RTKs) and two-component histidine 
kinase pathways (Dormann and Weijer, 2006; Wadhams and Armitage, 2004). Of these, 
chemotaxis mediated by RTKs is the least well understood. PDGF, EGF, VEGF and CSF1 
are among the chemoattractants that elicit RTK-based chemotaxis of different cell types, 
such as fibroblasts, epithelial and endothelial cells, and macrophages (Dormann and Weijer, 
2006; Shamloo et al., 2008; Webb et al., 1996). Although RTKs and GPCRs activate 
homologous enzymes (e.g., PI3K class 1A vs. class 1B; PLCγ vs. PLCβ, respectively), it is 
unclear whether or not the same signaling events are universally required for directed 
migration.
PDGF/PDGF receptor signaling is critical for mesenchymal lineages during embryonic 
development and for tissue homeostasis and wound repair, and has been implicated in 
diseases ranging from fibrosis to cancer (Andrae et al., 2008). The mesenchymal cells 
affected by PDGF signaling adhere firmly to extracellular matrix and exhibit high 
contractility using bundled actin stress fibers, limiting migration speed. Conversely, 
amoeboid cells move rapidly (>10× faster than mesenchymal cells) without strong adhesion 
and with contractility confined to the rear uropod. These different mechanics of migration 
correspond to differing biological roles, with mesenchymal cells participating in slow, 
collective responses in connective tissue, whereas amoeboid cells such as leukocytes 
constitute a ‘rapid response force’. Both types of cells exhibit chemotaxis, but it remains an 
open question whether or not the underlying mechanisms at the level of cytoskeletal 
dynamics and force generation are similar (Bear and Haugh, 2014).
Measuring chemotaxis is a challenge, particularly for slow-moving cells. Older methods 
such as the Boyden or transmembrane migration chamber have been widely used (Boyden, 
1962), but suffer from certain shortcomings. Perhaps most significant is that these 
measurements often do not distinguish between effects on the efficiency of migration (cell 
speed) versus directional bias, since treatments that affect either property might be 
interpreted as an effect on ‘chemotaxis’ (Zigmond and Hirsch, 1973). In addition, these 
chamber systems do not allow direct observation of the cells undergoing directed migration, 
so the molecular processes involved cannot be imaged. Several direct observation 
chemotaxis chambers have been developed (Zicha et al., 1991; Zigmond, 1977); however, 
issues such as limited gradient stability have restricted their application. More recently, 
microfluidic fabrication techniques have been used to make chambers in which gradients 
can be maintained for many hours (Li Jeon et al., 2002; Shamloo et al., 2008).
Using such a microfluidic chamber, we recently tested the ability of fibroblasts depleted of 
the Arp2/3 complex to chemotax towards PDGF and EGF (Wu et al., 2012; Wu et al., 2013). 
The Arp2/3 complex is a seven-subunit complex that forms branched actin structures found 
in lamellipodia; this function is actuated downstream of certain chemotactic signaling 
pathways, including the aforementioned PI3K (Rotty et al., 2013). Surprisingly, we found 
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that the Arp2/3 complex is dispensable for chemotaxis towards PDGF or EGF, provided that 
the media is exchanged during the experiment to flush out secreted factors produced by the 
Arp2/3-depleted cells (Wu et al., 2013). It is notable that the Arp2/3-depleted cells are 
unable to respond to surface-bound gradients of extracellular matrix (haptotaxis), indicating 
that RTK chemotaxis and haptotaxis have different requirements for cytoskeletal 
organization and dynamics (Wu et al., 2012). These results prompted us to probe the 
molecular mechanisms that link signal transduction, elicited by RTK ligands such as PDGF, 
to asymmetric force transduction by the cytoskeleton in mesenchymal cells.
Results
Signaling pathways implicated in amoeboid chemotaxis are dispensable for mesenchymal 
chemotaxis to PDGF
To address the mechanism of mesenchymal cell chemotaxis, we utilized a microfluidic 
chemotaxis chamber system established previously (Wu et al., 2012)(Fig. 1A (i)). In this 
system, we routinely generate 1 mm long, linear gradients of growth factors or small 
molecules that are stable for up to 24 hours and are compatible with a variety of live-cell 
imaging techniques (Fig. 1A (ii, iii)). To measure chemotaxis, cells migrating in the gradient 
chambers were tracked (Sup.Movies.1, 2; Fig. 1B (i)) and information about migration 
speed, persistence and directionality were extracted from the tracks. The migration speed 
and persistence (D/T ratio) were assessed by standard methods (Fig. S1A). Forward 
Migration Index (FMI), net distance moved in the direction of the gradient divided by total 
path length, was used to quantify directionality (Fig. S1A). For purposes of this study, we 
considered an FMI >0.1 to indicate positive chemotaxis, FMI with a 95% confidence 
interval encompassing zero to indicate no chemotaxis and an FMI < -0.1 to indicate chemo-
repulsion. Directionality was represented graphically as circular, wind-rose histograms, 
where length of each leaflet corresponds to the percentage of cells migrating in the direction 
of leaflet (Fig. 1B (ii)). It is important to note that wind-rose plots do not convey 
information about speed or persistence of cell migration. Although many treatments 
described in this study affected either migration speed or persistence, there seemed to be 
little correlation with directionality as reported by FMI. The relationship amongst these 
properties will be pursued in a separate study, with this work remaining focused on 
identifying the molecular pathway of directional sensing and response in mesenchymal cells. 
The specific PDGF-R inhibitor, AG-1296 (Kovalenko et al., 1997), blocked the chemotactic 
response (Fig. 1B (iii)), confirming the cognate mechanism of the apparent PDGF gradient 
sensing.
With this system, we sought to identify the pathway used by slow-moving mesenchymal 
cells such as fibroblasts for PDGF chemotaxis. Our previous results on the role of the 
Arp2/3 complex in chemotaxis relied on depletion by RNA interference or by the chemical 
inhibitor CK-666, neither of which ensures complete elimination of Arp2/3 function (Wu et 
al., 2012). To corroborate those findings, we assessed chemotaxis of fibroblasts derived 
from a conditional knockout of the Arpc2 gene, which encodes the essential p34 subunit of 
the Arp2/3 complex. In accord with our previous results, genetic deletion of Arp2/3 complex 
function does not block PDGF chemotaxis in our chamber system (Fig. 1C). Two pathways 
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that have been implicated in amoeboid chemotaxis are phosphoinositide 3-kinase (PI3K) and 
mammalian target of rapamycin (mTOR) (Parent and Devreotes, 1999; Swaney et al., 2010; 
Weiner, 2002). To determine whether or not these pathways are required for fibroblast 
chemotaxis to PDGF, we treated cells with inhibitors targeting either PI3K (PI3Kα inhibitor 
IV) or mTOR (AZD8055) during the chemotaxis experiment. These treatments block the 
expected signaling readouts effectively (Fig. S1B, C), but neither of them prevents PDGF 
chemotaxis of fibroblasts (Fig. 1D). PDGF chemotaxis in the absence of PI3K signaling 
corroborates previous findings (Melvin et al., 2011).
To extend these results, we turned to mesenchymal tumor cells derived from genetically 
engineered murine (GEM) models of melanoma harboring oncogenic mutations in pathways 
implicated in chemotaxis. The first cell line, LKB878, harbors two mutant copies of K-Ras 
(G12D) and lacks the tumor suppressor LKB1 (Liu et al., 2012). The second cell line, 
PBT-2460, harbors a mutation in B-Raf (V600E) and lacks PTEN (Hanna et al., 2013). Both 
of these cell lines exhibit mesenchymal morphology, with stress fibers and mature focal 
adhesions (Fig. S1D). We probed the pathways downstream of the PDGF receptor in these 
cell lines. Compared with control fibroblasts, the LKB878 cells showed elevated basal 
MEK/ERK signaling without PDGF stimulation and further activation of this pathway upon 
PDGF treatment. Akt activation appeared intact in this cell line. Conversely, the PBT-2460 
line showed substantial basal phosphorylation of both MEK/ERK and Akt and no further 
stimulation upon PDGF treatment (Fig. 1E). When these cell lines were analyzed in the 
microfluidic chambers, both displayed robust PDGF chemotactic responses (Fig. 1F). These 
data suggest that mutations in these signaling pathways, which affect amoeboid chemotaxis, 
do not affect mesenchymal chemotaxis to PDGF.
Myosin IIA is required for mesenchymal chemotaxis
These data beg the question: what is required for mesenchymal chemotaxis? One treatment 
that blocks PDGF chemotaxis in our chamber system is the Myosin II inhibitor, blebbistatin 
(BLB; Fig. 2A, Sup.Mov.3) (Straight et al., 2003). Although this drug alters cell 
morphology and cytoskeletal structure, the speed of locomotion of BLB-treated fibroblasts 
was similar to that of untreated controls (Fig. 2A,B). The effects of BLB were reversible, as 
chemotaxis resumed upon wash-out of this drug and re-establishment of the PDGF gradient 
in the chamber (Fig. 2A). Fibroblasts express two isoforms of Myosin II, MyoIIA and 
MyoIIB (Even-Ram et al., 2007; Vicente-Manzanares et al., 2008). To confirm and extend 
our BLB results, we depleted these isoforms separately using multiple independent siRNAs. 
Whereas depletion of MyoIIB did not affect chemotaxis, depletion of MyoIIA ablated PDGF 
chemotaxis in fibroblasts (Fig. 2C, S2A,B).
Non-canonical regulation of Myosin IIA via PKCα is required for mesenchymal chemotaxis
We reasoned that PDGF chemotaxis might be governed by asymmetric regulation of 
MyoIIA activity. The canonical pathway of Myosin II regulation involves activating 
phosphorylation of Threonine 18 and Serine 19 (Thr18/Ser19) on the regulatory light chain 
(RLC; also known as MLC-20) of the Myosin II complex by several kinases (Vicente-
Manzanares et al., 2009) (Fig. 3A). However, consistent with previous studies (Komatsu and 
Ikebe, 2007), stimulation of fibroblasts with PDGF, PMA (phorbol ester) or EGF produced 
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no increase in Ser19 phosphorylation (Fig. 3B, S3A). We also used correlative 
immunofluorescence to image pSer19 RLC during chemotaxis in the chamber and observed 
no bias in distribution of this modification relative to the PDGF gradient (Fig. S3B,C). To 
functionally confirm that Thr18/Ser19 phosphorylation does not play a major regulatory role 
in PDGF chemotaxis, we treated fibroblasts with either ROCK or MLCK inhibitors 
(Y27632, peptide 18) to inhibit the predominant kinases that phosphorylate Thr18/Ser19 in 
fibroblasts. Separately, neither of these treatments blocked PDGF chemotaxis. Consistent 
with the need for some Myosin II activity to execute chemotaxis, however, simultaneous 
inhibition of ROCK and MLCK blocked PDGF chemotaxis (Fig. 3C). Together, these data 
suggest that the canonical regulatory pathway of Myosin II is unlikely to play a major role in 
PDGF chemotaxis and that a different MyoIIA regulatory mechanism may be required.
Aside from the canonical regulatory pathway, Myosin II can also be regulated by non-
canonical pathways such as the inhibitory phosphorylation of RLC on Serines 1 and 2 by 
conventional PKCs such as PKCα (Fig. 3A) (Bengur et al., 1987; Ikebe et al., 1987; 
Kawamoto et al., 1989; Komatsu and Ikebe, 2007; Nishikawa et al., 1984; Varlamova et al., 
2001; Vicente-Manzanares et al., 2009). To assess the role of Ser1/2 inhibitory 
phosphorylation in PDGF chemotaxis, we generated GFP fusions of the wild-type RLC and 
a RLC mutant containing non-phosphorylatable alanine substitutions (S1AS2A) and 
expressed these in fibroblasts in a Dox-inducible manner. Upon expression, neither the wild-
type nor the mutant GFP fusions altered the phosphorylation of RLC Ser19, with or without 
PDGF/PMA stimulation (Fig. 3D). Consistent with previous studies using PDGF, expression 
of the S1AS2A RLC, but not the wild-type RLC, blocked the disassembly of actin stress 
fibers in response to PMA treatment (Fig. 3E) (Komatsu and Ikebe, 2007). Expression of the 
S1AS2A dominant-negative RLC blocked PDGF chemotaxis, whereas the wild-type RLC 
construct did not affect this process (Fig. 3F). These data indicate that regulation of MyoIIA 
via Ser1/2 RLC inhibitory phosphorylation is critical for PDGF chemotaxis.
Expression profiling showed that PKCα is the only conventional PKC isoform expressed in 
IA32 fibroblasts (Wu et al., 2013). To test whether or not PKCα is required for PDGF 
chemotaxis in fibroblasts, we inhibited this kinase using the small molecule inhibitor 
Gö6976 (Martiny-Baron et al., 1993). This compound blocked PDGF chemotaxis in a 
reversible manner (Fig. 4A). To corroborate this result, we depleted PKCα using multiple 
independent siRNAs (Fig. S4A) and confirmed that this too blocks PDGF chemotaxis (Fig. 
4B, S4B). One possibility is that PKCα activity is required for events unrelated to 
directional migration, such as maintenance of a specific gene expression pattern. To rule out 
this possibility, we generated a gradient of Gö6976 in our microfluidic chamber system. 
Fibroblasts in this gradient (without exogenous PDGF present) display chemo-repulsion, 
migrating away from the higher drug concentration (Fig. 4C). This result was confirmed 
using a gradient of LY333531, a structurally unrelated conventional PKC inhibitor (Fig. 
S4C). Interestingly, cells expressing the dominant-negative S1AS2A RLC construct were 
refractory to the chemo-repulsive effects of Gö6976 (Fig. 4C), as were cells depleted of 
PKCα (Fig. S4D). These data indicate that PDGF chemotaxis in fibroblasts involves the 
regulation of MyoIIA activity via phosphorylation of the non-canonical, inhibitory Ser1/2 
sites of RLC by PKCα.
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Localized DAG production by PLCγ is required for mesenchymal chemotaxis
Conventional PKC isoforms such as PKCα are activated by a combination of the membrane 
lipid diacylglycerol (DAG) and cytosolic calcium (Ca++) (Tanimura et al., 2002; Wu-Zhang 
and Newton, 2013). The enzyme PLCγ is activated directly by the PDGF receptor and 
hydrolyzes the phosphoinositide PIP2 to produce DAG and IP3, and the latter induces Ca++ 
release from intracellular stores (Hess et al., 1998). To test whether or not PLCγ is required 
for fibroblast chemotaxis to PDGF, we depleted PLCγ1 (the only isoform expressed in IA32 
fibroblasts) by multiple siRNAs and, in parallel, utilized PLCγ1-/- MEFs and their rescued 
derivative cell line (Fig. S5A). Both depletion and deletion of PLCγ1 blocked PDGF 
chemotaxis (Fig. 5A,B; S5B), indicating that signals generated by this enzyme are critical 
for directional migration towards PDGF.
To assess the role of intracellular Ca++ in PDGF chemotaxis, we used pharmacological 
inhibition of several potential sources of Ca++ To block IP3-mediated release of Ca++ from 
intracellular stores, we treated cells with Xestospongin-(c), a specific IP3 receptor inhibitor 
(Gafni et al., 1997). This treatment blocks PDGF-induced Ca++ increase in uniform 
application experiments (not shown) but did not block PDGF chemotaxis (Fig. 5C). To 
block mechanically sensitive Ca++ channels, we treated cells with Gd3+, a blocker of these 
channels (Yang and Sachs, 1989). In the presence of multiple concentrations of Gd3+, 
chemotactic response was intact, albeit with lower fidelity (Fig. S5C). Simultaneous 
treatment with Xestospongin-(c) and Gd3+ arrested all cell motility (not shown), and 
therefore we were unable to test for an effect on chemotaxis. Together, while these data 
confirm that cytosolic Ca++ is important for overall cell motility, they suggest that Ca++ is 
unlikely to be a significant directional determinant towards PDGF cues in our system.
To visualize the intracellular distribution of DAG, another signal generated by PLCγ in a 
PDGF gradient, we utilized a GFP-tagged fragment of PKCγ containing tandem C1 domains 
as a translocation biosensor for DAG (Oancea et al., 1998). Since our microfluidic chamber 
system allows high-resolution live-cell imaging, we visualized this probe by total internal 
reflection fluorescence (TIRF) microscopy. To verify the utility of this probe, we expressed 
it in the PLCγ1-depleted cells and observed no membrane recruitment of this probe to the 
ventral plasma membrane (imaged by TIRF) upon uniform PDGF stimulation, but did 
observe a bright signal with subsequent PMA stimulation (Fig. S5D). When this probe was 
expressed in control cells and imaged in a PDGF gradient, we observed a striking 
localization of DAG to the up-gradient portion of the cell that persisted for hours (Fig. 5D, 
Sup.Mov.4). Quantification of this localization (see methods, Fig. S5E) across many cells 
showed significant enrichment of this probe up-gradient, as compared with randomly 
migrating cells (Fig. 5E,F). These data indicate that DAG, produced locally by PLCγ1, is 
critical for fibroblast chemotaxis to PDGF.
Phorbol ester (PMA) gradients bypass the need for PDGF receptors and PLCγ, but not 
PKCα or Myosin II function
To functionally test the role of DAG in PDGF chemotaxis, we generated a gradient of the 
DAG-mimetic PMA in our microfluidic chamber system (Fig. 6A). Consistent with a 
positive, instructive role for DAG in this pathway, fibroblasts exposed to the PMA gradient 
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migrated towards the higher concentration of PMA (Fig. 6B). This PMA ‘chemotaxis’ was 
independent of PDGF receptor tyrosine kinase activity, as it still occurred in the presence of 
the PDGF-R inhibitor (Fig. 6C). A PMA gradient also bypasses the need for PLCγ1, as 
shown by the positive migration of PLCγ1-/- MEFs in this gradient (Fig. 6C). However, 
PMA was not able to bypass the need for PKCα or for Myosin II RLC Ser1/2 
phosphorylation in the directional migration response (Fig. 6D).
Localized inactivation of Myosin II at the leading edge is sufficient to promote directional 
migration
Our functional data support a model for PDGF chemotaxis that involves localized 
inactivation of Myosin IIA on the up-gradient side of the cell via the PLCγ1 → PKCα → 
RLC (Ser1/2) pathway. To visualize the organization of Myosin II during chemotaxis, we 
imaged either the wild-type or S1AS2A form of the GFP-tagged RLC by TIRF microscopy. 
Previous work has shown that Myosin II has a characteristic pattern of supramolecular 
organization from the leading edge of a mesenchymal cell towards the cell body (Svitkina et 
al., 1997). At the edge, a soluble pool of Myosin II accumulates into puncta or spots. These 
puncta coalesce into bundled fiber-like structures consistent with localization to stress fibers 
(Fig. S6A). At the leading edge of chemotaxing fibroblasts expressing the wild-type RLC-
GFP, we noted that puncta are enriched, whereas actomyosin bundles are largely absent 
(Sup. Mov. 5, left panel). We developed an image analysis method to segment and classify 
these structures using texture-based approaches (see methods, Fig. S6B). To quantify the 
Myosin II organization, we averaged the distribution of puncta and bundled structures across 
multiple cells in PDGF gradients. Consistent with our visual observations, cells expressing 
the wild-type RLC-GFP showed increased puncta and decreased stress fibers on the up-
gradient side of the cell (Fig. 7A), whereas S1AS2A-RLC-GFP showed even distribution of 
puncta and stress fibers around the perimeter of the cell (Fig. 7B, Sup. Mov. 5, right panel).
To further challenge our hypothesis about localized inactivation of Myosin II during 
fibroblast chemotaxis, we exposed cells to gradients of BLB in our microfluidic chamber 
system. It is important to note that we used a lower concentration of this drug in these 
gradient experiments than previous uniform treatments (3μM source, ∼1.75μM gradient 
midpoint). This cue promoted the positive migration of fibroblasts towards the higher 
concentration of BLB, although with a reduced FMI compared to PDGF chemotaxis (Fig. 
7C, Sup. Mov. 6, left panel). Uniform BLB treatment caused disassembly of actin stress 
fibers in both S1AS2A RLC-GFP- and wild-type RLC-GFP-expressing cells, consistent with 
BLB acting at the molecular interface between Myosin II and F-actin, downstream of Ser1/2 
phospho-regulation (Fig. S6C, 2B). Therefore, we reasoned that this gradient should bypass 
the S1AS2A dominant-negative RLC. Indeed, cells expressing the mutant construct showed 
positive migration towards BLB (Fig. 7C, Sup.Mov.6, right panel). We also imaged the 
localization of Myosin II in the BLB gradients for both wild-type and S1AS2A RLC-GFP 
by TIRF microscopy. At these sub-saturating BLB concentrations, stress fibers were reduced 
in the TIRF imaging, so we concentrated on the puncta. Consistent with the observed 
functional bypass by the BLB gradient, cells expressing either wild-type or S1AS2A RLC-
GFP showed increased puncta intensity on the up-gradient side of the cell (Fig. 7D, S6D). 
Together, these data indicate that localized inhibition of Myosin II by a gradient of BLB is 
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sufficient to provoke directional migration, with movement biased in the direction of 
decreasing Myosin II activity.
Discussion
Using our direct observation chemotaxis chamber, we have elucidated an obligate pathway 
for mesenchymal chemotaxis towards the RTK ligand PDGF (Fig. 7E). The PDGF receptor, 
upon activation, recruits PLCγ to produce a localized intracellular gradient of DAG. The 
critical enzyme that responds to this gradient is PKCα, which phosphorylates RLC at Ser1/2 
and thus inactivates MyoIIA at the leading edge of the chemotaxing cell. This localized 
Myosin II inactivation provides the asymmetry of force needed for directional migration. 
These results present a significant step forward in our understanding of chemotaxis in 
mesenchymal cells, but a number of questions arise from these findings.
Asymmetric PDGF receptor signaling and chemotaxis
PDGF receptors mobilize numerous signaling pathways via recruitment of adaptor proteins 
and enzymes to their auto-phosphorylated cytoplasmic tails. Although many of the signaling 
pathways downstream of the PDGF receptor are well understood from a biochemical, 
structural and kinetic perspective, understanding how they are regulated in a cell 
experiencing asymmetric stimulation as in chemotaxis presents a new set of challenges. Not 
only must individual signaling components and pathways be evaluated for their roles in 
chemotaxis, but also the spatial and temporal aspects of this signaling must be considered.
To break spatial symmetry, our data point to PLCγ as the key downstream enzyme that must 
be activated for fibroblasts to chemotax towards PDGF. One of the products of this enzyme, 
DAG, is maintained in a stable internal gradient within chemotaxing mesenchymal cells. 
Similar observations have recently been made during collective cell migration of endothelial 
cells in scratch assays (Tsai et al., 2014). This internal gradient can be partially phenocopied 
by providing cells with an extracellular gradient of the cell-permeable DAG analog, PMA. 
This suggests that an internal gradient of DAG is both necessary and sufficient to provide 
the asymmetric intracellular cue for chemotaxis. In future studies, it will be important to 
investigate how this internal gradient of DAG is maintained. Regulators of this internal 
gradient are likely to include the DAG kinases, which convert DAG into phosphatidic acid 
and thus limit the spatial range of DAG diffusion in the plasma membrane. The other 
product of PIP2 hydrolysis by PLCγ is IP3. Based on our inhibitor studies, the action of IP3 
prompting Ca++ release from internal stores is not required for PDGF chemotaxis, and 
neither is the action of stretch-activated Ca++ channels. These results stand in contrast with a 
previous study implicating Ca++ influx in the ability of fibroblasts to turn towards a PDGF 
gradient (Wei et al., 2009). As discussed in more detail below, certain signaling pathways 
might allow cells to reorient towards a gradient more efficiently, while at the same time 
being dispensable for chemotaxis. Intracellular Ca++ is likely to be important for directional 
migration in a variety of other contexts. Indeed, in monolayer migration of endothelial cells, 
pulses of Ca++ have been shown to activate Myosin II activity via MLCK to trigger 
retraction of the leading edge (Tsai and Meyer, 2012). The context-dependent source, 
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functional role, and localization of Ca++ during directional migration, and its relationship to 
differential Myosin II activity, will require further investigation.
Our studies have identified PDGF-R → PLCγ → PKCα → Myosin II as an obligate 
pathway for mesenchymal chemotaxis, but other pathways activated by the PDGF receptor 
likely contribute to the fidelity of this process and may prove to be required for chemotaxis 
under different conditions, such as shallower gradients (Bosgraaf et al., 2008). In support of 
this view, gradients of PDGF elicited greater chemotactic fidelity than did gradients of 
PMA, and still lower fidelity was promoted by gradients of BLB. This suggests that PI3K 
and possibly other signaling pathways triggered by PDGF likely enhance chemotaxis and/or 
the efficiency of the cells' alignment with the gradient (Welf et al., 2012) even though PI3K 
signaling, along with Rac (Monypenny et al., 2009) and the Arp2/3 complex (Wu et al., 
2012), are dispensable for executing this process.
A related question that arises is: where is the amplification found in our system? Stated 
another way, how does a mesenchymal cell convert a fairly shallow gradient of receptor 
occupancy on the cell surface into a robust internal gradient that leads to directed cell 
translocation? A common mechanism for amplification of chemical signaling is positive 
cooperativity or feedback (Iglesias and Devreotes, 2012; Jilkine and Edelstein-Keshet, 
2011). Such mechanisms at the level of PLC/PKC signaling will need to be explored. One 
interesting candidate is the regulation of cofilin activity downstream of PLCγ that has been 
observed during EGF chemotactic signaling in adenocarcinoma cells (Mouneimne et al., 
2006). Downstream of this pathway, another possible source of amplification is at the level 
of myosin contractility itself. A relatively modest change in local myosin activity could 
affect local F-actin organization in a nonlinear manner, thus magnifying changes in myosin 
activity. Further experiments will be required to discriminate between these and other 
possible mechanisms of amplification during mesenchymal chemotaxis towards RTK 
ligands.
Myosin II regulation and chemotaxis
At the heart of the pathway we have defined in this work is the generation of asymmetric 
Myosin II activity by chemotactic signaling. Although Myosin II activity has been linked to 
chemotaxis in amoeboid cells through genetic approaches, it has always been considered a 
peripheral player in this process, however, our data establish a central role of Myosin II in 
mesenchymal chemotaxis. In some ways, the role of Myosin II in chemotaxis is not 
surprising, since it is one of the main force generators in cells (along with actin 
polymerization). The pathway we have defined asymmetrically regulates Myosin II activity 
(and thus asymmetric force generation) not by selective activation, but by selective 
inactivation on the up-gradient side of the cell. Our data sheds new light on this problem and 
also raises several questions about how Myosin II is regulated and the role it plays in 
crawling cells.
Myosin II activity can be regulated by a variety of mechanisms, but the dominant mode of 
regulating this protein complex is through activating phosphorylation of Thr18/Ser19 on the 
RLC. Therefore, we were surprised to discover that this mechanism is not responsive to 
PDGF stimulation and does not appear to play a major role in PDGF chemotaxis. Instead, 
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our data indicate that non-canonical, inhibitory phosphorylation of RLC on Ser1/2 is critical 
for PDGF chemotaxis in fibroblasts. This inhibitory phosphorylation of this site was 
discovered in the 1980s, but it has received comparatively little attention relative to Thr18/
Ser19 phosphorylation. Although phosphorylation of Ser1/2 is dispensable for cytokinesis in 
HeLa cells (Beach et al., 2011), it is important for disassembly of stress fibers in response to 
PDGF or PMA (Komatsu and Ikebe, 2007). Recently, phosphorylation of Ser1/2 was 
identified as a critical regulatory mechanism for T cell polarization (Liu et al., 2013). 
Unfortunately, the molecular mechanism of the inhibitory effect of this phosphorylation is 
unknown. One proposed mechanism is that phosphorylation of Ser1/2 blocks or inhibits the 
phosphorylation of Thr18/Ser19 by kinases such as ROCK or MLCK (Ikebe et al., 1987), 
however our data argue against that possibility.
How does asymmetric Myosin II activity lead to directed cell migration? This question is 
likely to have a fairly complicated answer. Myosin II is an abundant protein with a 
significant role in organizing actin filament networks in cells, in addition to generating 
contractile force through its motor activity (Vicente-Manzanares et al., 2009). It is useful to 
consider the primary effects of Myosin II inhibition and the secondary consequences of 
those primary effects. Two primary effects of Myosin II inhibition are alterations in actin 
organization and filament integrity. Lower Myosin II activity will lead to slower formation 
of bundled actomyosin structures and stress fibers and less compaction of loose filament 
networks at the lamellipodium/lamella boundary. Myosin II activity has also been linked to 
actin filament severing (Wilson et al., 2010), and reduced severing in the up-gradient side of 
the cell could locally alter actin dynamics. The secondary effects of these changes could be 
slower actin retrograde flow and altered protrusion and focal adhesion dynamics. In a cell 
undergoing chemotaxis, these changes are biased by the PLCγ/PKCα pathway to the up-
gradient side of the cell, leading to the observed bias in cell translocation. Another possible 
outcome is that global gradients in Myosin II activity will result in higher overall 
contractility in the down-gradient side of the cell, promoting the squeezing of cellular 
contents towards the up-gradient side.
Chemotaxis across diverse cell types: different molecules, same principles?
One of the main findings in this paper is that mesenchymal cells such as fibroblasts use a 
molecular pathway for chemotaxis that is different than the pathways used by amoeboid 
cells. This finding highlights the diversity of chemotactic mechanisms that operate in 
different cell types. One possible source of this difference is the way that each cell type 
utilizes Myosin II. In mesenchymal cells, which are much more adherent, Myosin II is found 
throughout the cell and controls contractile stress fiber networks that span the cell from front 
to back. In amoeboid cells, which are far less-adherent, Myosin II is largely confined to the 
rear uropod, and no stress fibers are present. Therefore, mesenchymal cells may be 
particularly sensitive to mechanisms that locally control Myosin II activity. Another 
difference is the types of receptors that trigger the chemotactic response. Although some 
amoeboid cells are capable of responding to both RTK and GPCR ligands (Park et al., 
2011), the vast majority of studies on amoeboid chemotaxis have focused on GPCR ligands 
such as fMLP in neutrophils or extracellular cAMP for Dictyostelium cells. It will be 
interesting to examine RTK-driven chemotaxis in amoeboid cells or GPCR chemotaxis in 
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mesenchymal cells. Unfortunately, examination of the transcriptome generated by RNA-Seq 
has not revealed obvious candidate chemotactic GPCRs expressed in our fibroblasts 
(unpublished observation). Finally, our data indicate that perturbing a single pathway (PLCγ 
→ PKCα → Myosin IIA) in fibroblasts is sufficient to disrupt chemotaxis, whereas genetic 
studies in Dictyostelium amoebae have revealed a striking functional redundancy amongst at 
least five separate pathways in response to chemotactic stimulation (Swaney et al., 2010). 
Although we do not yet understand the difference between these two contexts, we speculate 
that the need for Dictyostelium cells to aggregate by chemotaxis under nutrient-poor 
conditions creates an intense selective pressure for redundancy.
Although the chemotactic pathway defined here for mesenchymal cells apparently uses 
different molecular players than amoeboid cells to achieve directed migration, it is worth 
considering the conceptual and functional similarities between these pathways. In both 
cases, soluble extracellular cues activate cell surface receptors in an asymmetric fashion. 
The signals must be converted into intracellular gradients of second messenger or 
intermediate molecules. This signaling module must be adept at both maintaining a robust 
pattern in the presence of long-term extracellular cues and changing rapidly to respond to 
new, acute stimuli, and it must effectively interface with the cytoskeletal network to produce 
the asymmetric force needed for directed cell translocation. In amoeboid cells, this force 
appears to be generated by actin polymerization in the protrusive pseudopod, whereas in 
mesenchymal cells, asymmetric force is generated by selective inactivation of Myosin II 
near the leading edge. A particularly intriguing problem in both instances is how the 
cytoskeletal or force-generating module feeds back into the signaling module to reinforce 
and refine directional migration.
Experimental Procedures
For complete methods, see the Extended Experimental Procedures found in the Online 
Supplemental Material.
Cell culture, viral transduction and plasmid/siRNA transfections
Cells were cultured in DMEM supplemented with 10% FBS (HyClone), 100 U/mL 
penicillin, 100 μg/mL streptomycin and 292 μg/mL L-glutamine. Retroviral packaging, 
infections, and fluorescence-activated cell sorting were performed as described (Bear et al., 
2000). Lentivirus production and infection were performed as described (Cai et al., 2008). 
K-Ras;LKB1-/- cells, B-Raf;Pten-/- cells and PLCγ1-/-, PLCγ1 rescue cells were kind gifts 
from Sharpless lab (UNC-CH), Kim lab (UNC-CH), and Sondek lab (UNC-CH) 
respectively. Cells expressing tagged tandem C1 domains were generated by transient 
transfection protocols and Myosin II, PKC and PLC knock down cells were generated using 
standard siRNA knockdown protocols. Arpc2-/- fibroblasts were generated from tail tissue 
of mice harboring a floxed Arpc2 allele in the Ink4a/Arf-/- genetic background.
Generation of MyoRLC-GFP cell lines
pLL6-MYH12A construct was made by replacing 5′LTR promoter in pLL5.0 (Cai et al, 
2008) with PTight promoter from pTRE-Tight Vector (Clontech) and inserting human 
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MYH12A using EcoRI-BamHI cloning sites. MYH12A insert was obtained by PCR from 
cDNA isolated from human cell line WM-266-4 (ATCC CRL-1676™). Point mutations in 
MYH12A were introduced using standard overlap extension technique using KOD 
polymerase (EMD Millipore). Tetracycline-inducible MYH12A WT and S1AS2A-mutant 
IA32 cell lines were made by first preparing a stable rtTA-expressing IA32 cells using 
pLenti-CMV-rtTA3-hygro lentivirus infection (virus made with Addgene plasmid 26730) 
and selection with 100ug/mL hygromycin. These stable rtTA cells were then infected with 
pLL6-MYH12A-GFP lentivirus, and subjected to 3 rounds of FACS: first, cells were 
induced with 1ug/mL Doxycycline (Dox) and sorted for GFP-positive cells. The resulting 
cell population was then allowed to recover to uninduced state in absence of Dox and sorted 
for no GFP expression, and, finally, the cell population obtained after this sort was induced 
with 1ug/mL Dox again and sorted for high GFP expression. Resulting Tet-inducible MLC 
populations were induced with 1μg/mL Doxycyclene for 24 hours before chemotaxis 
experiments.
Directional migration image acquisition and analysis
PDMS microfluidic devices were prepared as described previously (Wu et al., 2012). 
Chemotaxis assays were performed on an Olympus microscope with a 20× objective using 
Metamorph imaging software. Images were collected every 10 minutes for up to 24 hours. 
Individual cells were manually tracked using ImageJ software (Manual Tracking plugin). 
Only viable and visibly migrating cells (net path length > 50μm) were tracked during the 
experiments. The tracks obtained were analyzed using the Chemotaxis Tool ImageJ plugin 
(http://www.ibidi.de/applications/ap_chemotaxis.html#imageanalysis). This analysis tool 
was used to extract the forward migration index (FMI) along with the velocity of migration 
and the persistence of migration using the D/T ratio (net path length/total path length). 
Further, the plugin also generates histograms (count frequency) of migration direction of 
cells for each data set. The secplot function of Matlab was then used to generate rose plots 
of directional migration on normalized polar coordinates where the outer most ring 
corresponds to frequency (r) of 8%.
Analysis of the DAG pattern
To correlate the intensity of DAG in a cell and direction of chemotaxis, a signalling map of 
the Tandem c1 probe was created. These fluorescent intensity maps were created for each 
cell by a process of thresholding, masking and segmenting within angular bins relative to 
cell centriod (supplementary methods, Welf et al., 2012). The normalized pattern are then 
averaged over all the cells for each condition to produce an aggregate plot. The linear 
(unbinned) plots are smoothed by local regression using weighted linear least squares and a 
first-degree polynomial mode. The cumulative DAG signal is then presented as a histogram 
with a bin size of 10 degrees for chemotaxing cells (n = 12 cells) and randomly migrating (n 
= 13 cells)(Fig. 5E, 5F). A similar approach was used to analyze the distribution of pSer19 
of RLC in chemotaxing cells (Fig. S3B).
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Analysis of Myosin II organization
Analysis similar to one described above was used. Due to the obscured visibility and 
discontinuity of the cell outline in cells expressing RLC-GFP constructs, a convex hull was 
created around the original cell mask. Using two-dimensional median filtering (Fig. 
S6B(1)), puncta (Fig. S6B(2)) and stress fibers in the outer ring of the convex hull mask are 
segmented. Each of the pixels associated with puncta and stress fibers are assigned to an 
angular bin with respect to the cell centroid (1 count per pixel); any bin containing both 
puncta and stress fibers are counted as stress fibers. Plots are then generated in the same 
manner as described above for the DAG pattern (See supplement). The data for the wild-
type RLC-GFP-expressing cells in the PDGF gradient are shifted by the median angle of 
migration (not including angles more than 90° from the direction of the PDGF gradient), 
resulting in a 25-degree shift to the right. During migration in response to a BLB gradient, 
very few stress fibers were visible under TIRF imaging. Analysis was therefore performed 




AlexaFluor dyes conjugated to phalloidin were from Invitrogen. Antibodies were purchased 
from Cell Signaling Technology, ECM Biosciences and Santa Cruz Biotechnology. PDGF-
BB was purchased from BD Biosciences and PMA from Sigma. Inhibitors of PDGF-R, 
PI3K and MLCK were purchased from Calbiochem, Pan-tor inhibitor, Blebbistatin and 
MLCK and ROCK inhibitor from Sigma Aldrich, and Gö6976 was purchased from Tocris. 
siRNAs were purchased as a set of four from Qiagen for Myosin IIA (GS17886), Myosin 
IIB (GS77579), PKCα (GS18750) and PLCγ1 (GS18803).
Cell culture, viral transduction and plasmid/siRNA transfections
Cells were cultured in DMEM supplemented with 10% FBS (HyClone), 100 U/mL 
penicillin, 100 μg/ml streptomycin and 292 μg/mL L-glutamine. Transient transfections 
were performed using FuGene 6 (Roche) for HEK293 FT cells and NanoJuice (EMD 
Millipore) for fibroblast cell lines. Retroviral packaging, infections, and fluorescence-
activated cell sorting were as described (Bear et al., 2000). Lentivirus production and 
infection were as described (Cai et al., 2008). K-Ras;LKB1-/- cells, B-Raf;Pten-/- cells and 
PLCγ1-/-, PLCγ1 rescue cells were kind gifts from Sharpless lab (UNC-CH), Kim lab 
(UNC-CH), and Sondek lab (UNC-CH). Tagged tandem C1 domains from PKCγ, (C1)2-
GFP, was transiently transfected into IA32 fibroblasts using NanoJuice reagent. The cells 
were sorted using a Biorad S3 sorter 18 h post-transfection. The sorted cells were 
immediately loaded into the chemotaxis chamber for cell migration assays. siRNA for each 
gene was purchased as a FlexiTube Gene Solution set from Qiagen and reconstituted 
following manufacturer's instructions in nuclease-free water. IA32 fibroblasts were 
transfected at 50% confluency using 25-50pmol of siRNA and RNAiMAX transfection 
reagent (Life Technologies) following the manufacturer's protocol. Knockdown was 
analyzed by blotting and/or immunofluorescence 48-96 hours post-transfection.
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Generation of Arpc2-/- fibroblasts
Homozygous mice carrying a floxed Arpc2 allele were maintained in an Ink4a/Arf null 
genetic background. All mice were maintained in IACUC approved housing and had free 
access to standard food and water. Euthanization of mice and harvesting of tissue was also 
carried out under IACUC approved protocols. Adult mice were sacrificed and tails were 
harvested for isolation of tissue fibroblasts. The superficial dermis was peeled away and 
remaining tail was minced into small pieces, which were placed directly onto gelatin-coated 
plates and incubated in DMEM supplemented with 10% FBS, 1% Pen/Strep, and 1% 
Glutamax. After five days, tail chunks were removed and bulk fibroblast cultures were 
expanded according to normal fibroblast culture conditions. These cells were then stably 
transduced with a CreER-expressing retrovirus (made with Addgene plasmid 22776) and 
subjected to puromycin selection. Bulk populations of puro-resistant adult tail fibroblasts 
were sorted as single cells into each well of a 96 well plate. Clones were continuously 
cultured and expanded to 10 cm dishes. Clonal lines were tested for responsiveness to 
tamoxifen by treatment of a subset of cells with 2 uM 4-hydroxytamoxifen (4-OHT) to 
stimulate CreER activity on days one and three of culture. On day five, treated (KO) cells 
and untreated (WT, pre-Cre) control cells were expanded and cultured side by side. At this 
point they were analyzed for loss of p34 (encoded by the Arpc2 gene) via western blotting 
and immunofluorescence, and tested for chemotaxis. A more complete characterization of 
these cells will be reported separately.
Microfludic device preparation
The pattern for the chemotaxis chamber was fabricated on 4″ silicon wafers using a two-step 
photolithography process. The first step involved spin coating a 5 micron tall layer of SU-8 
(25) from microposit and transfer of the microcapillaries to the wafer. After developing the 
first layer a second 100 micron tall layer of SU-8 (100) was applied to the same wafer and 
after alignment the channels were transferred to the wafer. After developing and post-
baking, the silicon wafer was exposed to silane overnight. Polymethylsiloxane (PDMS) was 
poured on the wafer and cured overnight in a 70° C oven. Individual PDMS devices were 
cut out from the wafer and placed in a clean dish until use. The sharp ends of 20 gauge 
needles were cut off and then smoothed using a Dremel tool. The needles were then used to 
punch out ports in the devices. The devices were then washed with water and ethanol, blow-
dried and exposed to air plasma for 2 mins in a plasma cleaner (Harrick plasma). Glass 
bottom culture dishes (MatTek) or Delta T dishes (Bioptechs) dishes were cleaned using 
water and ethanol and then exposed to plasma for 2 mins. The PDMS device was placed in 
contact with glass dish immediately following plasma treatment of both pieces, ensuring that 
an irreversible seal was formed. The cell culture chamber was then filled with 10 μg/mL FN 
for 15mins at 37° C, followed by flushing with sterile PBS. Cells were loaded into the cell 
culture chamber using a gel loading pipette tip. The cell chamber ports were plugged with 
short pieces of tubing (Upchurch Scientific, .0025″ × 1/32″) before gradient formation.
Chemotactic gradients
The exit ports of the sink and source channels were connected to waste using tubing of ID 
0.015″. Gas tight 100 μL Hamilton glass syringes (81020,1710TLL 100ul SYR) were 
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connected to 27 1/2 gauge needles connected to tubing. The source syringe and tubing were 
filled with DMEM containing indicated chemoattractant/pharmacological drug and 0.01 
μg/mL of TRITC/Cy5-dextran to visualize the gradient. The sink syringe and tubing were 
filled with DMEM. The tubing was then inserted into the source and sink channels 
respectively, and the syringe pump was operated at a flow rate of 20 nL/min. A stable 
gradient was then established in the cell culture chamber within 30 min, and typically 
remained stable for almost 24 hr as monitored by dextran fluorescence intensity.
Immunofluorescence
For immunofluorescent staining, the cells were fixed, stained and mounted as described 
previously (Bear et al., 2002). Cells were plated on acid-washed coverslips coated with 10 
μg/mL FN overnight before fixing with 4% PFA and permeabilized in 0.1% Triton X-100 in 
PBS for 5 mins. Cells were then blocked for 15 mins in PBS containing 5% normal goat 
serum (Jackson Laboratories) and 5% fatty-acid-free BSA. Primary antibodies were applied 
to cells in PBS containing 1% BSA for 1 hr at room temperature. Cells were stained in 
various combinations with AlexaFluor-647 phalloidin for F-actin (1:200 dilution), Myosin-
RLC (MLC-20; 1:250 dilution) or Vinculin (1:250 dilution) antibodies. After washing the 
cells three times in PBS, fluorescent dye conjugated secondary antibodies were diluted to 
1:250 in 1% BSA in PBS and applied to the coverslips for 1 hr. After three washes in PBS, 
the coverslips were mounted onto slides with Fluoromount G (Electron Microscopy 
Sciences). Images were captured using a FluoView scanning confocal inverted microscope 
(FV1000, Olympus) equipped with a 40× objective, a Hamamatsu PMT and controlled by 
Fluoview software. Maximum intensity projection was determined with ImageJ from a z-
stack.
TIRF microscopy
The microfluidic chamber system is fully integrated with live-cell TIRF microscopy 
imaging. A 60× TIRF objective was used to image the translocation of (C1)2-GFP or 
localization of the RLC-GFP constructs during chemotaxis. The cells were imaged at 2-
minute intervals for 5-10 hours.
Analysis of the DAG pattern
A mask of the cell is created via threshholding and removing small isolated groups of pixels 
(Fig S5E(1)). A mask of the cell periphery is created from the whole cell mask by erosion of 
edges and subtracting the resulting image from the cell mask (Fig. S5E(2)). Locally enriched 
signaling regions are determined in the periphery mask (2) by segmenting contiguous 
regions (at least 15 pixels) with intensity values that exceed a set number (1.2) of standard 
deviations above the mean intensity of the periphery mask (Fig. S5E(3)). Any pixels 
completely enclosed by enriched pixels are also included (outlined in magenta). In a method 
similar to one described previously (Welf et al., 2012), the intensity values of the segmented 
pixels are summed within angular bins relative to the cell centroid in each image. This is 
done for each time point to create a signaling “map” (Fig. S5E(4)) with the angle plotted on 
the horizontal axis and time on the vertical axis. To quantify the overall signaling pattern for 
each cell, the values in each angular bin is averaged over all time points and then normalized 
such that the mean across all bins is equal to 1. These normalized patterns are then averaged 
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over all the cells for each condition to produce an aggregate plot. The linear (unbinned) plots 
are smoothed by local regression using weighted linear least squares and a first-degree 
polynomial mode. The cumulative DAG signal is then presented as a histogram with a bin 
size of 10 degrees for chemotaxing cells (n = 12 cells) and randomly migrating (n = 13 cells)
(Fig. 5E, 5F). A similar approach was used to analyze the distribution of pSer19 of RLC in 
chemotaxing cells.
Analysis of Myosin II organization
As in the analysis of DAG, masks of the cell and cell periphery are created. Due to the 
obscured visibility and discontinuity of the cell outline in cells expressing RLC-GFP 
constructs, a convex hull around the original cell mask is used to calculate the cell centroid 
as well as to exploit the fact that stress fibers reside almost exclusively in concave regions. 
Using two-dimensional median filtering (Fig. S6B(1)), puncta (Fig. S6B(2)) and stress fibers 
in the outer ring of the convex hull mask are segmented. A larger geometry and lower 
threshold is used for segmenting stress fibers due to their larger size (Fig. S6B(3)). Median-
filtered objects are organized by size, objects of only a few pixels are removed, and large 
objects with high aspect ratios are identified as stress fibers (any other large objects are 
removed). If a stress fiber is identified in one frame, median-segmented regions that overlap 
with it in the next frame are also considered stress fibers if they have a high aspect ratio. 
This aids in the detection of stress fibers that might not be fully segmented by the median 
filter in every frame. Each of the pixels associated with puncta is assigned to an angular bin 
with respect to the cell centroid (1 count per pixel); any bin containing both puncta and 
stress fibers are counted as stress fibers. To correct for discontinuous stress fibers missed 
between frames, any angular bin marked as containing stress fibers more than half the time 
during a 15-frame interval is marked as a stress fiber for the entire interval. After this 
procedure, each angular bin is classified as puncta, stress fiber, or neither. To plot the 
distribution of puncta, stress fiber bins are set to zero, and vice-versa for the stress fiber 
distribution. The plots are generated in the same manner as described above for the DAG 
pattern. The data for the wild-type RLC-GFP-expressing cells in the PDGF gradient are 
shifted by the median angle of migration (not including angles more than 90° from the 
direction of the PDGF gradient), resulting in a 25-degree shift to the right. During migration 
in response to a BLB gradient, very few stress fibers were visible under TIRF imaging. 
Analysis was therefore performed in the same manner as for the DAG pattern to quantify 
RLC-GFP regions at the cell periphery.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Pathways that are dispensable for mesenchymal chemotaxis
A. (i) A 3D schematic of the microfluidic chamber used for chemotaxis experiments. (ii) 
The fluorescent micrograph shows the formation of Cy5 dextran gradient in the channel. (iii) 
A line scan of fluorescent intensity of the gradient indicates that a linear gradient is formed 
in the chamber with an approximate slope of 43%.
B. (i) Migratory tracks of IA32 fibroblast chemotaxing to a PDGF gradient (ii) Cell tracks of 
chemotaxing cells represented as a wind-rose plot (number of cell tracked (n) = 62). Each 
leaflet represents the count frequency of cells migrating in the corresponding angular bin. 
Forward Migration Index (FMI), persistence (D/T) and velocity values are indicated below 
the plot, +/- 95% C.I. (iii) Wind-rose plot showing inhibition of chemotaxis to PDGF in the 
presence of a uniform concentration of PDGF-R inhibitor, AG1296 (1 μM) (n = 68).
C. Wind-rose plots of PDGF chemotaxis of WT (pre-Cre deletion) (n=82) and Arpc2 KO (n 
= 71) MEFs.
D. Directional migration response of fibroblasts to PDGF gradient in the presence of 
uniform PI3Kα inhibitor IV (5 μM) (n = 74) or m-TOR inhibitor AZD8055 (1 μM) (n = 56).
E. Western blot analysis of fibroblasts and melanoma cells stimulated with PDGF for the 
indicated incubation times, ns indicates not serum-starved. Phosphorylation of ERK, MEK, 
Akt and S6K1 were assessed.
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F. Chemotaxis of K-Ras/Lkb1 null (Melanoma 1) (n = 72) and B-Raf/Pten null (Melanoma 
2) (n = 81) tumor cell lines to a PDGF gradient.
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Figure 2. Myosin IIA is required for chemotaxis, whereas Myosin IIB is dispensable
A. Rose plot showing loss of chemotaxis in the presence of uniform concentration of 
blebbistatin (BLB, 15 μM) (n = 123) and recovery of chemotactic migration after wash-out 
of BLB (n = 97).
B. Immunofluorescence of IA32 fibroblasts shows myosin light chain (GFP) and F-actin 
(red, Phalloidin) in cells before and after uniform BLB treatment.
C. Circular histograms showing chemotaxing control cells, loss of chemotactic migration in 
Myosin IIA KD (n = 80) cells and intact chemotaxis in Myosin IIB KD cells (n = 61).
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Figure 3. Chemotaxis requires regulation of Myosin II function via non-canonical RLC 
phosphorylation
A. Schematic of Myosin Regulatory Light Chain (Myo RLC) showing phospho-regulatory 
sites Ser1/Ser2 and Thr18/Ser19. Ser1/Ser2 are inhibitory phosphorylation sites regulated by 
conventional PKCα. Thr18/Ser19 are activating phosphorylation sites regulated by ROCK 
and MLCK.
B. Western blot analysis to probe the extent of Ser19 phosphorylation of Myosin II RLC, 
which shows no change in response to PDGF or PMA stimulation.
C. Wind-rose plots of cell migration show PDGF chemotaxis in the presence of either 
ROCK inhibitor Y27632 (15 μM) (n = 161) or MLCK inhibitor peptide 18 (10 μM) (n = 
104). When added together, the ROCK and MLCK inhibitors impede chemotactic migration 
to PDGF (n = 94).
D. Western blot analysis of Ser19 phosphorylation of Myosin II RLC after PDGF or PMA 
stimulation of both MyoRLC-GFP and MyoRLC(S1AS2A) cells shows no change in Ser19 
phosphorylation of either the endogenous or GFP-tagged RLC.
E. Immunofluorescence images of MyoRLC-GFP and MyoRLC(S1AS2A)-GFP cells show 
disassembly of actin stress fibers in wild-type cells and no disassembly in myosin mutant 
cells upon PMA stimulation.
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D. Wind-rose plots showing chemotaxing control MyoRLC-GFP cells (n=61) and non-
chemotaxing mutant MyoRLC(S1AS2A)-GFP cells (n= 73) in a PDGF gradient.
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Figure 4. PKCα is essential for chemotaxis
A. Wind-rose plots of fibroblasts in a PDGF gradient show inhibition of chemotaxis in the 
presence of a uniform concentration of PKCα inhibitor, Gö6967 (1 μM) (n=162) and 
recovery of chemotaxis after drug wash-out (n=88).
B. Circular histograms show chemotaxis of wild-type fibroblasts in a PDGF gradient and the 
lack of chemotactic response of PKCα KD cells (n=68) in the same chamber.
C. Chemo-repulsion of wild-type cells to gradients of Gö6967 (n=101). Mutant MyoRLC 
(S1AS2A) cells do not exhibit directional migration in a gradient of Gö6967 (n=89).
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Figure 5. PLCγ is essential for PDGF chemotaxis and produces an asymmetric pattern of 
intracellular DAG
A. Wind-rose plot of control cells migrating in a PDGF (n=67) gradient and loss of 
directional migration of PLCγ KD cells (n=70) in the same chamber.
B. Fibroblasts derived from PLCγ-null (PLCγ1-/-) (n=73) mice show a loss of chemotactic 
response to PDGF. Upon rescue of PLCγ expression, these fibroblasts regained their ability 
to chemotax (n=101).
C. Circular histogram of cells chemotaxing to PDGF gradients in a uniform concentration of 
Xestospongin-(c) (1 μM) (n=69).
D. Montage of an IA32 fibroblast transfected with GFP-tagged tandem C1 domain [(C1)2-
GFP] chemotaxing to PDGF for more than five hours.
E. Enriched pixels in a chemotaxing cell are shown outlined in magenta. The intensity 
values of the segmented pixels are summed within angular bins at each time point to create a 
signaling “map” with the angle plotted on the horizontal axis and time on the vertical axis. 
Histogram showing the cumulative intracellular DAG distribution in chemotaxing cells 
expressing (C1)2-GFP (n=12 cells).
F. Enriched pixels in a randomly migrating cell are shown outlined in magenta. The 
intensity values of the segmented pixels are summed within angular bins at each time point 
to create a signaling “map” with the angle plotted on the horizontal axis and time on the 
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vertical axis. Histogram showing the cumulative intracellular DAG distribution in randomly 
migrating cells expressing (C1)2-GFP (n=13 cells).
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Figure 6. Phorbol ester (PMA) gradients bypass the need for PDGF receptors and PLCγ, but not 
PKCα or Myosin II function
A. Wind-rose plot of IA32 fibroblasts chemotaxing in PMA gradients (n=89).
B. Wind-rose plots show that PMA gradients rescue chemotaxis of both IA32 fibroblasts in 
a uniform concentration of PDGF-R inhibitor AG1296 (1 μM) (n=45) and that of PLCγ1 -/- 
fibroblasts (n=61).
C. Circular histograms showing no rescue of chemotaxis of PKCα KD (n=85) or mutant 
Myo-RLC(S1AS2A) cells (n=187) in PMA gradients.
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Figure 7. Asymmetric Myosin II organization and activity are hallmarks of chemotactic 
migration in mesenchymal cells
A. TIRF microscopy movies of chemotaxing MyoRLC-GFP cells are analyzed to identify 
puncta (blue) and stress fiber regions (red). The localization of puncta and stress fibers 
relative to the cell centroid were averaged across multiple cells (n=11 cells) and presented as 
histograms.
B. Analysis of puncta and stress fiber distributions, quantified as in A, in 
MyoRLC(S1AS2A)-GFP cells (n=36cells).
C. Circular histograms of MyoRLC-GFP (n=162) and MyoRLC(S1AS2A) (n=67) cells 
chemotaxing in a gradient of BLB.
D. Intensity of MyoRLC-GFP and MyoRLC(S1AS2A)-GFP during chemotaxis in a BLB 
gradient, presented as a histogram.
E. Proposed model of PDGF chemotaxis: PDGF binds to PDGFR, recruits PLCγ to produce 
a localized intracellular gradient of DAG. The asymmetric DAG phosphorylates RLC at 
Ser1/2 via PKCα, inactivating MyoIIA at the leading edge of the chemotaxing cell. This 
localized Myosin II inactivation provides the asymmetry of force needed for directional 
migration.
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